Fact CheckerSign in

NCT07448428Not yet recruiting

Generalized Pustular Psoriasis Registry in Costa Rica

National Registry of Patients With Generalized Pustular Psoriasis Treated Within the Costa Rican Social Security System

Source: ClinicalTrials.gov · Last updated 9 Mar 2026

Brief summary (registry, in English)

The goal of this observational registry study is to characterize the clinical, epidemiological, and therapeutic features of patients with generalized pustular psoriasis (GPP) in Costa Rica through a standardized national registry. The main question it aims to answer is: What are the clinical, epidemiological, and therapeutic characteristics of patients with generalized pustular psoriasis registered in the country, and how do these relate to disease severity and evolution? Patients with GPP receiving routine dermatologic care in participating centers will have their demographic, clinical, severity, comorbidity, and treatment data recorded using a standardized case report form. Clinical assessments (e.g., GPPASI, PASI/BSA, DLQI), laboratory results, triggers, complications, and therapies will be documented and updated during periodic follow-up visits as part of usual care.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
26 Feb 2026
Start date
May 2026
Primary completion date
May 2031
Lead sponsor
Caja Costarricense de Seguro Social
Diseases
Psoriasis
NCT number
NCT07448428

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From May 2026 to the primary completion date, May 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients without a confirmed diagnosis of generalized pustular psoriasis (GPP) or with alternative pustular dermatoses (e.g., acute generalized exanthematous pustulosis) not meeting GPP diagnostic criteria.
  • Absence of verifiable diagnosis in the institutional electronic health record (EDUS) or insufficient documentation to confirm GPP.
  • Patients whose clinical records lack the minimum data required for registry variables or follow-up within routine care.

Who the study is looking for

  • Confirmed diagnosis of generalized pustular psoriasis (GPP) established by a board-certified dermatologist based on compatible clinical and/or histopathologic criteria.
  • Registered diagnosis of GPP in the institutional electronic health record system (EDUS code L401) during the study period.
  • Patients of any age and sex receiving care within participating centers of the Costa Rican Social Security system.
  • Availability of clinical information sufficient for registry data entry and follow-up according to routine care.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Caja Costarricense del Seguro Social
Coordinator of this site? Confirm its status
San JoséCosta RicaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.